AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 294: G1033-G1040, 2008. First published February 28, 2008; doi:10.1152/ajpgi.00507.2007
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/G1033    most recent
00507.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larauche, M.
Right arrow Articles by McRoberts, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larauche, M.
Right arrow Articles by McRoberts, J. A.

NEUROREGULATION AND MOTILITY

Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats

Muriel Larauche,14 Sylvie Bradesi,14 Mulugeta Million,14 Peter McLean,7 Yvette Taché,14 Emeran A. Mayer,13,5,6 and James A. McRoberts13

1Department of Medicine, 2Center for Neurovisceral Sciences and Women's Health, 3Center for Ulcer Research and Education: Digestive Disease Research Center, 5Departments of Physiology, Psychiatry, and Behavioral Sciences, and 6Brain Research Institute, David Geffen School of Medicine at University of California, Los Angeles; 4Veterans Affairs, Greater Los Angeles Healthcare System, Los Angeles, California; and 7GlaxoSmithKline (Neurology and Gastrointestinal Centre for Excellence for Drug Discovery), Harlow, United Kingdom

Submitted 2 November 2007 ; accepted in final form 25 February 2008

Visceral hypersensitivity has been implicated as an important pathophysiological mechanism in functional gastrointestinal disorders. In this study, we investigated whether the sustained visceral hyperalgesia induced by repeated psychological stress in rats involves the activation of CRF1 signaling system using two different antagonists. Male Wistar rats were exposed to 10 consecutive days of water avoidance stress (WAS) or sham stress for 1 h/day, and the visceromotor response to phasic colorectal distension (CRD) was assessed before and after the stress period. Animals were injected subcutaneously with the brain penetrant CRF1 antagonist, CP-154,526, acutely (30 min before the final CRD) or chronically (via osmotic minipump implanted subcutaneously, during stress) or with the peripherally restricted, nonselective CRF1 and CRF2 antagonist, astressin, chronically (15 min before each stress session). Repeated WAS induced visceral hypersensitivity to CRD at 40 and 60 mmHg. CP-154,526 injected acutely significantly reduced stress-induced visceral hyperalgesia at 40 mmHg but not at 60 mmHg. Chronic subcutaneous delivery of astressin reduced the stress-induced visceral hyperalgesia to baseline at all distension pressures. Interestingly, chronically administered CP-154,526 eliminated hyperalgesia and produced responses below baseline at 40 mmHg and 60 mmHg, indicating a hypoalgesic effect of the compound. These data support a major role for CRF1 in both the development and maintenance of visceral hyperalgesia induced by repeated stress and indicate a possible role of peripheral CRF receptors in such mechanisms.

visceral nociception; astressin; CP-154,526; water avoidance



Address for reprint requests and other correspondence: J. McRoberts, UCLA, 14-103 Warren Hall, 900 Veteran Ave., Los Angeles, CA 90095 (e-mail: mcrobert{at}ucla.edu)




This article has been cited by other articles:


Home page
Br Med BullHome page
A. D. Farmer and Q. Aziz
Visceral pain hypersensitivity in functional gastrointestinal disorders
Br. Med. Bull., September 1, 2009; 91(1): 123 - 136.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Larauche, G. Gourcerol, L. Wang, K. Pambukchian, S. Brunnhuber, D. W. Adelson, J. Rivier, M. Million, and Y. Tache
Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways
Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G215 - G227.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Sweetser, M. Camilleri, S. J. Linker Nord, D. D. Burton, L. Castenada, R. Croop, G. Tong, R. Dockens, and A. R. Zinsmeister
Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?
Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1299 - G1306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Bradesi, V. Martinez, L. Lao, H. Larsson, and E. A. Mayer
Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats
Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G302 - G309.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Chotiwat and R. B. S. Harris
Antagonism of specific corticotropin-releasing factor receptor subtypes selectively modifies weight loss in restrained rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1762 - R1773.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.